Activation of epidermal growth factor receptor signaling by the prostaglandin E2 receptor EP4 pathway during gastric tumorigenesis

Cancer Science

Volumn 102, Issue 4, 2011, Pages 713-719

  Oshima, Hiroko ^a   Popivanova, Boryana K ^a   Oguma, Keisuke ^a   Kong, Dan ^a   Ishikawa, Tomo O ^a   Oshima, Masanobu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; ADAM17 PROTEIN; ADAM8 PROTEIN; ADAM9 PROTEIN; AMPHIREGULIN; BETACELLULIN; CELECOXIB; DISINTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIREGULIN; GEFITINIB; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; PROSTAGLANDIN E RECEPTOR; UNCLASSIFIED DRUG; WNT1 PROTEIN;

ARTICLE; CARCINOGENESIS; GASTRIC TUMORIGENESIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; STOMACH TUMOR; TRANSGENIC MOUSE;

ADAM PROTEINS; ANIMALS; ANTIGENS, CD; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOSKELETAL PROTEINS; DINOPROSTONE; DISEASE MODELS, ANIMAL; DISINTEGRINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION PROFILING; GLYCOPROTEINS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952756393     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01847.x     Document Type: Article

References (43)

1. Gupta RA, DuBois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001; 1: 11-21.
2. Wang D, DuBois RN. Eicosanoids and cancer. Nat Rev Cancer 2010; 10: 181-93.
3. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-9.
4. Δ716 knockout mice. Nat Med 2001; 7: 1048-51.
5. Δ716 mouse intestinal polyps. Cancer Res 2002; 62: 506-11.
6. Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K, DuBois RN. Cyclooxigenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol 2005; 2: 254-66.
7. Roberts RB, Min L, Washington MK et al. Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis. Proc Natl Acad Sci USA 2002; 99: 1521-6.
8. Torrance CJ, Jackson PE, Montgomery E et al. Combinatorial chemoprevention of intestinal neoplasia. Nat Med 2006; 6: 1024-8.
9. Buchanan FG, Holla V, Katkuri S, Matta P, DuBois RN. Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer. Cancer Res 2008; 67: 9380-8.
10. 2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem 2003; 278: 35451-7.
11. Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN. Role of β-arrestin1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci USA 2006; 103: 1492-7.
12. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 2002; 8: 289-93.
13. 2 stimulates the growth of colon cancer cells via induction of amphiregulin. Cancer Res 2003; 63: 5218-23.
14. 2 stimulates Id-1 transcription. J Biol Chem 2008; 283: 33955-68.
15. Al-Salihi MA, Ulmer SC, Doan T et al. Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-α converting enzyme. Cell Signal 2007; 19: 1956-63.
16. Oshima H, Oshima M, Inaba K, Taketo MM. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J 2004; 23: 1669-78.
17. Guo X, Oshima H, Kitamura T, Taketo MM, Oshima M. Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. J Biol Chem 2008; 283: 19864-71.
18. Stadtlander CT, Waterbor JW. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 1999; 20: 2195-207.
19. Saukkonen K, Rintahaka J, Sivula A et al. Cyclooxygenase-2 and gastric carcinogenesis. APMIS 2003; 111: 915-25.
20. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res 1993; 53: 1322-7.
21. Clements WM, Wang J, Sarnaik A et al. β-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 2002; 62: 3503-6.
22. 2 pathway. Gastroenterology 2006; 131: 1086-95.
23. 2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer. BMC Genomics 2009; 10: 615.
24. 2 pathway promotes gastric hamartoma development with suppression of bone morphogenetic protein signaling. Cancer Res 2009; 69: 2729-33.
25. 2, Wnt and BMP in gastric tumor mouse models. Cancer Sci 2009; 100: 1779-85.
26. Takeuchi K, Tanaka A, Kato S, Aihara E, Amagase K. Effect of (S)-4-(1-(5-Chloro-2-(4-fluorophenyoxy)benzamido)ethyl) benzoic acid (CJ-42794), a selective antagonist of prostaglandin E receptor subtype 4, on ulcerogenic and healing responses in rat gastrointestinal mucosa. J Pharmacol Exp Ther 2007; 322: 903-12.
27. Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci 2007; 98: 621-8.
28. Sahin U, Weskamp G, Kelly K et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004; 164: 769-79.
29. Sanderson MP, Erickson SN, Gough PJ et al. ADAM10 mediates ectodomain shedding of the betacellulin precursor activated by p-aminophenylmercuric acetate and extracellular calcium influx. J Biol Chem 2005; 280: 1826-37.
30. Horiuchi K, Gall SL, Schulte M et al. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol Biol Cell 2007; 18: 176-88.
31. Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol 2009; 9: 259-70.
32. Yarden Y, Sliwkowski MX. Untangling the ErbB signaling network. Nat Rev Mol Cell Biol 2001; 2: 127-37.
33. Tanida S, Joh T, Itoh K et al. The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells. Gastroenterology 2004; 127: 559-69.
34. Mazzocca A, Coppari R, De Franco R et al. A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res 2005; 65: 4728-38.
35. Fogel M, Gutwein P, Mechtersheimer S et al. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 2003; 362: 869-75.
36. Romano M, Ricci V, Di Popolo A et al. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN28 gastric mucosal cells. J Clin Invest 1998; 101: 1604-13.
37. Keates S, Sougioultzis S, Keates AC et al. cag+ Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Biol Chem 2001; 276: 48127-34.
38. Wallasch C, Crabtree JE, Bevec D et al. Helicobacter pylori-stimulated EGF receptor transactivation requires metalloprotease cleavage of HB-EGF. Biochem Biophys Res Commun 2002; 295: 695-710.
39. Yan F, Cao H, Chaturvedi R et al. Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. Gastroenterology 2009; 136: 1297-307.
40. 2 and promotes cancer progression. Cancer Res 2006; 66: 6649-56.
41. Myung SJ, Rerko RM, Yan M et al. 15-hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proc Natl Acad Sci USA 2006; 103: 12098-102.
42. 2 mediated by EP4 receptor in colorectal cancer. BMC Cancer 2009; 9: 207.
43. Oshima H, Hioki K, Popivanova BK et al. Prostaglandin E2 signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors. Gastroenterology 2010 Nov 9. [Epub ahead of print]